Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Kearney

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|February 13, 2019
Adverse Effects of PhysostigmineAnn M Arens, Tom Kearney
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 16, 2019
Correction to: Adverse Effects of PhysostigmineAnn M Arens, Tom Kearney
Journal of Clinical Pharmacy and Therapeutics|January 17, 2019
An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control SystemHien Nguyen, Angel Pan, Craig Smollin, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|June 24, 2008
Dietary supplement adverse events: report of a one-year poison center surveillance projectChristine Haller, Tom Kearney, Stephen Bent, et al.
Clinical Toxicology (Philadelphia, Pa.)|July 14, 2017
Safety and effectiveness of physostigmine: a 10-year retrospective review<sup/>Ann M Arens, Krishna Shah, Suad Al-Abri, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|February 13, 2019
Adverse Effects of PhysostigmineAnn M Arens, Tom Kearney
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 16, 2019
Correction to: Adverse Effects of PhysostigmineAnn M Arens, Tom Kearney
Journal of Clinical Pharmacy and Therapeutics|January 17, 2019
An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control SystemHien Nguyen, Angel Pan, Craig Smollin, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|June 24, 2008
Dietary supplement adverse events: report of a one-year poison center surveillance projectChristine Haller, Tom Kearney, Stephen Bent, et al.
Clinical Toxicology (Philadelphia, Pa.)|July 14, 2017
Safety and effectiveness of physostigmine: a 10-year retrospective review<sup/>Ann M Arens, Krishna Shah, Suad Al-Abri, et al.
Pageof 1